Dara Biosciences, Inc. (DARA) Reports Q2 Loss of 24c/Share

Dara Biosciences, Inc. (NASDAQ: DARA) reported Q2 EPS of ($0.24), $0.27 better than last year. Revenue for the quarter came in at $409.4 thousand.

For earnings history and earnings-related data on Dara Biosciences, Inc. (DARA) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• BofA maintains underperform ratings on six BDC stocks
• Ross Stores, Inc. (ROST) PT Raised to $240 at Bernstein SocGen Group